IMMUNITRACK ApS: Financial statements 2020
CVR: 32347908
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,089,608 and a net result of DKK -1,229,951 compared with DKK -2,303,315 the year before. Equity amounted to DKK 4,878,360. The solvency ratio was 67.2%. The company had 8 employees in the financial year.
- Gross Profit
- 1,089,608 kr.
- Profit/Loss
- -1,229,951 kr.
- Equity
- 4,878,360 kr.
- Total Assets
- 7,256,548 kr.
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.1 mio. | -1.2 mio. | 4.9 mio. | 8 |
| 2019 | - | -457 t. | -2.3 mio. | 6.1 mio. | 6 |
| 2018 | - | 2.5 mio. | 1.7 mio. | 3.5 mio. | 4 |
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
How creditworthy is IMMUNITRACK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 1, 2020, Stephen Clive Langford Gibbons has joined the board of directors of IMMUNITRACK ApS.
About IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity amounted to DKK 21,211,816.
